Penpulimab in Combination With Cetuximab as First-line Treatment in R/M SCCHN
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Metastatic Cancer
Related studies linked through entity extraction aliases.
Augsburg Longitudinal Plasma Study for the Evaluation of Liquid Biopsy as Diagnostic Tool.
- Status
- RECRUITING
- Phase
- N/A
Treat Primary and Metastatic Liver Tumors
- Status
- WITHDRAWN
- Phase
- N/A
Advanced Planning for Online Accounts and Data
- Status
- WITHDRAWN
- Phase
- NA
Advance Care Planning in the Emergency Department
- Status
- COMPLETED
- Phase
- NA
(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
- Status
- RECRUITING
- Phase
- PHASE3
Immune Therapy in HR-positive/HER2-negative Metastatic Breast Cancer(ENIGMA)-BCTOP-L-M02
- Status
- RECRUITING
- Phase
- PHASE2
Actinium 225 Labeled Anti-CEA Antibody (Ac225-DOTA-M5A) for the Treatment of CEA Producing Advanced or Metastatic Cancers
- Status
- RECRUITING
- Phase
- PHASE1
Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Study of NG-350A Plus Pembrolizumab in Metastatic or Advanced Epithelial Tumours (FORTIFY)
- Status
- COMPLETED
- Phase
- PHASE1
Expanded Access of Adagrasib (MRTX849) in Patients With Advanced Solid Tumors Who Have a KRAS G12C Mutation
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Assessment of Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic Malignancy
- Status
- UNKNOWN
- Phase
- N/A
A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Holmium-166 Retrospective Collection of Real-World Data
- Status
- COMPLETED
- Phase
- N/A
Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Prospective Validation of a Points Score System Predicting 30-day Survival
- Status
- RECRUITING
- Phase
- N/A
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of HMBD-002, a Monoclonal Antibody Targeting VISTA, as Monotherapy and Combined With Pembrolizumab, in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Using a PET Imaging Agent, 18F-Clofarabine (CFA), to Measure Deoxycytidine Kinase Activity in Metastatic Cancer
- Status
- TERMINATED
- Phase
- EARLY_PHASE1